Skip to main content
. Author manuscript; available in PMC: 2020 Nov 1.
Published in final edited form as: Cardiol Clin. 2019 Aug 26;37(4):365–384. doi: 10.1016/j.ccl.2019.07.003

Figure 6.

Figure 6.

Suggested algorithm for the evaluation for pulmonary hypertension in patients on dasatinib. Adapted from Weatherald J, Chaumais MC, Savale L, et al. Long-term outcomes of dasatinib-induced pulmonary arterial hypertension: a population-based study. Eur Respir J. 2017;50(1); with permission.